CHARLEEN SHELLEY: Open Payments
NPI 1669002515 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,943 in 94 payments from 27 companies in 2025. Trend: 2023 $19 · 2024 $1,243 · 2025 $1,943
Food & beverage: $1,927Education: $16
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 14 | $266 |
| ABBVIE INC. | 9 | $241 |
| AstraZeneca Pharmaceuticals LP | 11 | $204 |
| GlaxoSmithKline, LLC. | 7 | $154 |
| Janssen Biotech, Inc. | 7 | $141 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Daiichi Sankyo Inc. | 4 | $96 |
| PFIZER INC. | 3 | $80 |
| Eisai Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
Products named: KEYTRUDA, Enhertu, CARVYKTI, IBRANCE, Lenvima, JEMPERLI, ELAHERE, EPKINLY.
Industry payments across MO — which companies pay providers there.
